Loading...
XNYSMED
Market cap172mUSD
Jan 10, Last price  
15.80USD
1D
1.02%
1Q
-12.32%
Jan 2017
-62.05%
Name

Medifast Inc

Chart & Performance

D1W1MN
XNYS:MED chart
P/E
1.74
P/S
0.16
EPS
9.09
Div Yield, %
42.25%
Shrs. gr., 5y
-2.00%
Rev. gr., 5y
16.43%
Revenues
1.07b
-32.94%
27,340,00040,129,00074,086,00083,779,000105,445,000165,618,000257,552298,189,000356,706,000356,886,000285,285,000272,773,000274,534,000301,563,000501,003,000713,672,000934,842,0001,526,087,0001,598,577,0001,072,054,000
Net income
99m
-30.75%
1,747,0002,727,0005,082,0003,837,0005,435,00011,963,00019,61118,541,00015,876,00023,969,00013,181,00020,058,00017,835,00027,721,00055,789,00077,916,000102,859,000164,031,000143,568,00099,415,000
CFO
148m
-24.11%
2,332,0003,213,0005,845,0007,954,0005,496,00020,313,00028,769,00034,870,00040,264,00042,360,00025,536,00029,411,00025,350,00043,237,00060,816,00084,261,000145,196,00094,545,000194,570,000147,657,000
Dividend
Sep 18, 20231.65 USD/sh
Earnings
Feb 18, 2025

Profile

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
URL
https://medifastinc.com/
IPO date
Dec 30, 1993
Employees
874
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,072,054
-32.94%
1,598,577
4.75%
Cost of revenue
950,252
1,418,271
Unusual Expense (Income)
NOPBT
121,802
180,306
NOPBT Margin
11.36%
11.28%
Operating Taxes
29,382
40,491
Tax Rate
24.12%
22.46%
NOPAT
92,420
139,815
Net income
99,415
-30.75%
143,568
-12.48%
Dividends
(73,017)
(71,620)
Dividend yield
9.95%
5.51%
Proceeds from repurchase of equity
(6,960)
(127,961)
BB yield
0.95%
9.84%
Debt
Debt current
11,770
5,776
Long-term debt
38,139
46,326
Deferred revenue
Other long-term liabilities
16,566
Net debt
(100,132)
(35,589)
Cash flow
Cash from operating activities
147,657
194,570
CAPEX
(6,483)
(16,681)
Cash from investing activities
(61,047)
(11,414)
Cash from financing activities
(79,789)
(199,581)
FCF
100,953
178,771
Balance
Cash
150,041
87,691
Long term investments
Excess cash
96,438
7,762
Stockholders' equity
174,908
139,887
Invested Capital
115,378
187,900
ROIC
60.95%
74.97%
ROCE
57.50%
100.68%
EV
Common stock shares outstanding
10,921
11,276
Price
67.22
-41.73%
115.35
-44.92%
Market cap
734,110
-43.56%
1,300,687
-47.43%
EV
633,978
1,265,098
EBITDA
134,909
191,286
EV/EBITDA
4.70
6.61
Interest
701
Interest/NOPBT
0.39%